NB
Najat Bouchkouj
Pediatrics
Credentials: ·
History
Pediatrics
Research
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
Clinical Cancer Research · 2019 · Co-first of 10 authors · Corresponding · 196 citations
Journal of the National Cancer Institute · 2022 · 32 citations
Review · European Journal of Cancer · 2022 · 31 citations

2 papers
- DP
2 papers
- GR
2 papers
- MT
2 papers
- TP
2 papers
- YK
2 papers

1 paper
- AQ
1 paper

